Drug Type Monoclonal antibody |
Synonyms IPG 0521, IPG0521 |
Target |
Mechanism CCR8 inhibitor(C-C chemokine receptor type 8 inhibitor) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseIND Application |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | IND Application | CN | - | |
Immunoglobulin G4-Related Disease | Preclinical | CN | 04 Apr 2023 |